BMS-1001;D-Serine, N-[[2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]-5-methylphenyl]methyl]-;2113650-03-4 (free base);BMS 1001,BMS1001;BMS-1001, 10 mM in DMSO
BMS-1001 is a potent inhibitor of PD-1/PD-L1 interaction (IC50: 2.25 nM in homogeneous time-resolved fluorescence binding assay); it alleviates the inhibition of T-cell receptor-mediated T-lymphocyte activation by soluble PD-L1.